Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis
NCT04120090
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Hemophagocytic Lymphohistiocytosis
Interventions
DRUG:
low dose ruxolitinib
DRUG:
high dose ruxolitinib
Sponsor
Beijing Friendship Hospital